Zobrazeno 1 - 4 of 4 pro vyhledávání: '"E. S. Antonarakis"'
3
PSA doubling time (PSADT) and serum testosterone (T) during intermittent androgen deprivation (IAD) in patients with biochemically relapsed prostate cancer (BRCP; M0): Potential predictive implications
Autor: D. Keizman, P. Huang, E. S. Antonarakis, V. J. Sinibaldi, M. A. Carducci, S. R. Denmeade, M. A. Eisenberger
Publikováno v: Journal of Clinical Oncology. 29:150-150
150 Background: The systemic management of patients with BRPC remains controversial. IAD is commonly employed. Aims: To evaluate the PSA dynamics and serum T in pts with BRPC treated with IAD until the development of PSA refractoriness or clinical ev
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1e1935dce0d8087d7fd8d9f91a64eac1
https://doi.org/10.1200/jco.2011.29.7_suppl.150
Zobrazit plný text záznamu
4
Association of PTEN loss with outcome of patients (pts) with early high-risk prostate cancer (CaP) treated with adjuvant docetaxel following radical prostatectomy (RP)
Autor: D. Keizman, Z. Zhang, A. DeMarzo, B. Gurel, T. Lotan, J. Hicks, E. Rosenbaum, E. S. Antonarakis, M. A. Carducci, M. A. Eisenberger
Publikováno v: Journal of Clinical Oncology. 29:43-43
43 Background: Loss of the PTEN tumor suppressor and subsequent activation of the PI3K pathway is common and has potential clinical and therapeutic value in CaP. We examined the PTEN status of primary tumors in pts who underwent adjuvant docetaxel tx
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1262f33ec4862a545aa72257bbb4efd5
https://doi.org/10.1200/jco.2011.29.7_suppl.43
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje